Unusual polypoid mass in the colon

Article information

Korean J Intern Med. 2025;.kjim.2024.327
Publication date (electronic) : 2025 February 17
doi : https://doi.org/10.3904/kjim.2024.327
1Department of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
2Department of Pathology, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Correspondence to: Jong Ok Kim, M.D., Ph.D., Department of Pathology, Daejeon St. Mary Hospital, College of Medicine, The Catholic University of Korea, 64 Daeheung-ro, Jung-gu, Daejeon 34943, Korea, Tel: +82-42-220-9611, Fax: +82-42-220-9843, E-mail: jkim@catholic.ac.kr, https://orcid.org/0000-0002-3632-2998
Received 2024 September 19; Revised 2024 October 18; Accepted 2024 November 8.

A 79-year-old male visited the outpatient department for a screening colonoscopy. A 4.5 × 2.0 cm lobulated polypoid mass was detected 20 cm above the anal verge in the sigmoid colon (Fig. 1A). The lesion in the colon was a localized mass with suspicion of lymphoma. Due to inconclusive biopsy results, endoscopic submucosal dissection (ESD) was performed for both diagnostic and therapeutic purposes. After admission, ESD was performed (Fig. 1B). Endoscopic ultrasound revealed a hypoechoic lesion located between the mucosal and submucosal layers (Fig. 1C). Pathologically, the specimen showed a thickened mucosa and monomorphic small lymphoid cell infiltration in the expanded lamina propria with nondestructive glands (Fig. 1D, 2A). These lymphoid cells expressed CD3+, CD5+, CD8+, low Ki-67 expression (less than 5%), CD20−, CD79a−, CD4−, CD56−, granzyme B−, CD10−, BCL6−, CD30−, cyclin D1−, and EBV-encoded small RNA by in situ hybridization (Fig. 2B–H). The molecular pathology identified monoclonal T-cell receptor (TCR) β, δ, and γ gene rearrangement, leading to a diagnosis of indolent T-cell lymphoproliferative disorder of gastrointestinal tract (iTLPD-GI). The patient was asymptomatic, and given the successful endoscopic resection and the low morbidity associated with the disease, we opted for follow-up observation without further treatment [1]. The patient remains alive for three years. Initially described as iTLPD-GI, it was reclassified as indolent T-cell lymphoma of the gastrointestinal tract (iTCL-GI) in the 5th edition of the WHO classification [24].

Figure 1

(A) A lobulated polypoid mass measuring 4.5 × 2.0 cm was observed 20 cm above the anal verge during colonoscopy. (B) A fresh mass was identified in the endoscopic submucosal dissection specimen. (C) Endoscopic ultrasonography revealed a hypoechoic lesion located between the mucosa and submucosa. (D) Top: cut surfaces of the mass fixed in formalin showed a raised, flat, solid mass. Bottom: a microscopic image from scanned glass slides revealed lymphoid cells infiltrating the thickened mucosa (hematoxylin and eosin stain [H&E], ×0.4).

Figure 2

Histopathologic examination. (A) Dense small lymphoid cells infiltrate the expanded lamina propria without significant epitheliotropism. These lymphoid cells are positive for (B) CD3, (C) CD5, and (D) CD8, but negative for (E) CD20, (F) CD4, and (G) CD56. (H) The Ki-67 proliferation index is less than 5% (A: H&E, ×200; B–G: immunohistochemistry, ×200; H: immunohistochemistry, ×400).

During colonoscopy, iTCL-GI may present mucosal thickening, nodularity, polyps, irregular mucosal surfaces, and ulcers [5]. A key diagnostic feature of iTCL-GI is clonal small T cells infiltrating the expanded lamina propria without epitheliotropism. Immunohistochemistry and TCR gene rearrangement analysis are essential for diagnosis. Non-neoplastic diseases and other lymphomas should be excluded. Clinicians and pathologists must recognize this rare entity, and clinicopathological correlations are crucial for an accurate diagnosis.

Notes

CRedit authorship contributions

Seung-Woo Lee: conceptualization, writing - original draft; Jong Ok Kim: writing - original draft, writing - review & editing

Conflicts of interest

The authors disclose no conflicts.

Funding

None

Ethical statement

This case was approved by the Institutional Review Board of Daejeon St. Mary Hospital, College of Medicine, Catholic University of Korea (IRB No. DC24ZAS10058).

References

1. Sanguedolce F, Zanelli M, Zizzo M, et al. Indolent T-cell lymphoproliferative disorders of the gastrointestinal tract (iTLPD-GI): a review. Cancers (Basel) 2021;13:2790.
2. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues 4th edth ed. Lyon: International Agency for Research on Cancer; 2017.
3. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 2022;36:1720–1748.
4. WHO Classification of Tumours Editorial Board WHO classification of tumours, Haematolymphoid tumours Part B 5th edth ed. Lyon: International Agency for Research on Cancer; 2024.
5. Matnani R, Ganapathi KA, Lewis SK, Green PH, Alobeid B, Bhagat G. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update. Hematol Oncol 2017;35:3–16.

Article information Continued

Figure 1

(A) A lobulated polypoid mass measuring 4.5 × 2.0 cm was observed 20 cm above the anal verge during colonoscopy. (B) A fresh mass was identified in the endoscopic submucosal dissection specimen. (C) Endoscopic ultrasonography revealed a hypoechoic lesion located between the mucosa and submucosa. (D) Top: cut surfaces of the mass fixed in formalin showed a raised, flat, solid mass. Bottom: a microscopic image from scanned glass slides revealed lymphoid cells infiltrating the thickened mucosa (hematoxylin and eosin stain [H&E], ×0.4).

Figure 2

Histopathologic examination. (A) Dense small lymphoid cells infiltrate the expanded lamina propria without significant epitheliotropism. These lymphoid cells are positive for (B) CD3, (C) CD5, and (D) CD8, but negative for (E) CD20, (F) CD4, and (G) CD56. (H) The Ki-67 proliferation index is less than 5% (A: H&E, ×200; B–G: immunohistochemistry, ×200; H: immunohistochemistry, ×400).